|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
4/30/2010 8:07:16 AM
Seattle PI -- Mirina, the microRNA drug developer at Accelerator, raised $3.9 million in its "expansion round" of financing that was reported earlier this week, according to a regulatory filing. The money ought to be enough to operate the company inside Accelerator for another 12-15 months as the company seeks to nail down more intellectual property around some advantages of its microRNA therapies, says Accelerator CEO Carl Weissman. Brian Atwood of Versant Ventures has joined the Mirina board, which also includes Weissman, Thong Le of WRF Capital, Steve Gillis of Arch Venture Partners, Chad Waite of OVP Venture Partners, Merl Hoekstra of Elitech Group, according to the filing.
|
|
|
|
|
|
|
|
|
|
|